Cox regression analysis for MSS showed that CD9 expression, along with tumor ulceration and sentinel node status, was an independent predictor of melanoma specific survival in patients with cutaneous melanoma (p < 0.001; Table 3). The gene discussed is CD9; the disease is neoplasm.